559 related articles for article (PubMed ID: 15454139)
41. Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma.
Boolbol SK; Fey JV; Borgen PI; Heerdt AS; Montgomery LL; Paglia M; Petrek JA; Cody HS; Van Zee KJ
Ann Surg Oncol; 2001; 8(1):20-4. PubMed ID: 11206219
[TBL] [Abstract][Full Text] [Related]
42. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
[TBL] [Abstract][Full Text] [Related]
43. Reliability of identification of 655 sentinel lymph nodes in 263 consecutive patients with malignant melanoma.
Ariyan S; Ariyan C; Farber LR; Fischer DS; Flynn SD; Truini C
J Am Coll Surg; 2004 Jun; 198(6):924-32. PubMed ID: 15194074
[TBL] [Abstract][Full Text] [Related]
44. Indocyanine green and fluorescence lymphangiography for sentinel lymph node identification in cutaneous melanoma.
Cloyd JM; Wapnir IL; Read BM; Swetter S; Greco RS
J Surg Oncol; 2014 Dec; 110(7):888-92. PubMed ID: 25124992
[TBL] [Abstract][Full Text] [Related]
45. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer.
Derossis AM; Fey J; Yeung H; Yeh SD; Heerdt AS; Petrek J; VanZee KJ; Montgomery LL; Borgen PI; Cody HS
J Am Coll Surg; 2001 Nov; 193(5):473-8. PubMed ID: 11708502
[TBL] [Abstract][Full Text] [Related]
46. [Lymph nodes mapping for detection of sentinel nodes in patients with papillary thyroid cancer].
Nakano S; Uenosono Y; Ehi K; Arigami T; Higashi Y; Maeda T; Kijima Y; Natsugoe S; Aikou T
Gan To Kagaku Ryoho; 2004 May; 31(5):801-4. PubMed ID: 15170997
[TBL] [Abstract][Full Text] [Related]
47. Detection of sentinel lymph nodes in cervical cancer. A comparison of two protocols.
Kraft O; Sevcík L; Klát J; Koliba P; Curík R; Kríozvá H
Nucl Med Rev Cent East Eur; 2006; 9(1):65-8. PubMed ID: 16791808
[TBL] [Abstract][Full Text] [Related]
48. Improved lymphatic mapping technique for breast cancer.
Beitsch PD; Clifford E; Whitworth P; Abarca A
Breast J; 2001; 7(4):219-23. PubMed ID: 11678798
[TBL] [Abstract][Full Text] [Related]
49. Subareolar subcutaneous injection of blue dye versus peritumoral injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients.
Reitsamer R; Peintinger F; Rettenbacher L; Prokop E; Sedlmayer F
World J Surg; 2003 Dec; 27(12):1291-4. PubMed ID: 14574485
[TBL] [Abstract][Full Text] [Related]
50. Obesity influences outcome of sentinel lymph node biopsy in early-stage breast cancer.
Derossis AM; Fey JV; Cody HS; Borgen PI
J Am Coll Surg; 2003 Dec; 197(6):896-901. PubMed ID: 14644276
[TBL] [Abstract][Full Text] [Related]
51. Sentinel lymph node biopsy in breast cancer: results of intradermal periareolar tracer injection and follow-up of sentinel lymph node-negative patients.
van Wessem KJ; Meijer WS
Breast; 2004 Aug; 13(4):290-6. PubMed ID: 15325663
[TBL] [Abstract][Full Text] [Related]
52. Thorough intraoperative analysis of breast sentinel lymph node biopsies: histologic and immunohistochemical findings.
D'Errico A; Grassigli A; Gruppioni E; Fiorentino M; Corti B; Gabusi E; Morselli-Labate AM; Grigioni WF
Surgery; 2004 Mar; 135(3):248-54; discussion 255-7, 357. PubMed ID: 14976473
[TBL] [Abstract][Full Text] [Related]
53. Comparison of different injection sites of radionuclide for sentinel lymph node detection in breast cancer: single institution experience.
Mudun A; Sanli Y; Ozmen V; Turkmen C; Ozel S; Eroglu A; Igci A; Yavuz E; Tuzlali S; Muslumanoglu M; Cantez S
Clin Nucl Med; 2008 Apr; 33(4):262-7. PubMed ID: 18356664
[TBL] [Abstract][Full Text] [Related]
54. Subareolar and peritumoral injection identify similar sentinel nodes for breast cancer.
Bauer TW; Spitz FR; Callans LS; Alavi A; Mick R; Weinstein SP; Bedrosian I; Fraker DL; Bauer TL; Czerniecki BJ
Ann Surg Oncol; 2002 Mar; 9(2):169-76. PubMed ID: 11888875
[TBL] [Abstract][Full Text] [Related]
55. Use of radiotracer for sentinel lymph node mapping in breast cancer optimizes staging independent of site of administration.
Kesmodel SB; Canter RJ; Terhune KP; Bauer TW; Mick R; Rosato EF; Spitz FR; Fraker DL; Alavi A; Czerniecki BJ
Clin Nucl Med; 2006 Sep; 31(9):527-33. PubMed ID: 16921275
[TBL] [Abstract][Full Text] [Related]
56. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer.
Cox CE; Pendas S; Cox JM; Joseph E; Shons AR; Yeatman T; Ku NN; Lyman GH; Berman C; Haddad F; Reintgen DS
Ann Surg; 1998 May; 227(5):645-51; discussion 651-3. PubMed ID: 9605656
[TBL] [Abstract][Full Text] [Related]
57. Sentinel lymph node biopsy in breast cancer: review on various methodological approaches.
Zengel B; Yararbas U; Sirinocak A; Ozkok G; Denecli AG; Postaci H; Uslu A
Tumori; 2013; 99(2):149-53. PubMed ID: 23748806
[TBL] [Abstract][Full Text] [Related]
58. Is the "10% rule" equally valid for all subsets of sentinel-node-positive breast cancer patients?
Chung A; Yu J; Stempel M; Patil S; Cody H; Montgomery L
Ann Surg Oncol; 2008 Oct; 15(10):2728-33. PubMed ID: 18688679
[TBL] [Abstract][Full Text] [Related]
59. Intradermal radioisotope injection is superior to subdermal injection for the identification of the sentinel node in breast cancer patients.
Motomura K; Komoike Y; Hasegawa Y; Kasugai T; Inaji H; Noguchi S; Koyama H
J Surg Oncol; 2003 Feb; 82(2):91-6; discussion 96-7. PubMed ID: 12561063
[TBL] [Abstract][Full Text] [Related]
60. Complementarity of blue dye and isotope in sentinel node localization for breast cancer: univariate and multivariate analysis of 966 procedures.
Cody HS; Fey J; Akhurst T; Fazzari M; Mazumdar M; Yeung H; Yeh SD; Borgen PI
Ann Surg Oncol; 2001; 8(1):13-9. PubMed ID: 11206218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
